Skip to main content
Signal8
Launch Terminal

Cresco Labs Inc. (CRLBF)

Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.

Sector: Medicinal Chemicals & Botanical Products

Industry: Drug Manufacturers - Specialty & Generic

Cresco Labs Inc. logo

Cresco Labs Inc.

OTC:CRLBFHealthcare
-5.54%$0.6000
Mkt Cap$221.59M
Float343.86M
O/S369.32M
Inst Own-
SI0.3%
Dilution
Cresco Labs Inc. logoOTC:CRLBF$0.6000-5.54%
FormDescription
6-K
Foreign Private Issuer Report
2
6-K
Foreign Private Issuer Report
6
6-K
Foreign Private Issuer Report
4
6-K
Foreign Private Issuer Report
40-F
Canadian Annual Report
6-K
Foreign Private Issuer Report
EFFECT
Notice of Effectiveness
6-K
Foreign Private Issuer Report
F-X
SEC Filing
F-10
SEC Filing
6-K
Foreign Private Issuer Report
TO-I/A
SEC Filing
6-K
Foreign Private Issuer Report
TO-I
SEC Filing
TO-C
SEC Filing
6-K
Foreign Private Issuer Report
6-K
Foreign Private Issuer Report
6-K
Foreign Private Issuer Report
6-K
Foreign Private Issuer Report
13G/A
Beneficial Ownership Report (Amended)
40-F
Canadian Annual Report
6-K
Foreign Private Issuer Report
13G
Beneficial Ownership Report
13G/A
Beneficial Ownership Report (Amended)
6-K
Foreign Private Issuer Report

1-25 of 92